FITC Anti-Human CD8a Antibody[OKT-8]

FITC Anti-Human CD8a Antibody[OKT-8]

The FITC Anti-Human CD8a Antibody[OKT-8] is a monoclonal antibody that is designed to specifically target and bind to the CD8a antigen found on human T cells. This antibody is conjugated with fluorescein isothiocyanate (FITC), which allows for easy detection and visualization of CD8a-positive cells using flow cytometry or fluorescence microscopy. The OKT-8 clone of this antibody has been extensively validated and is widely used in research and clinical applications.

CD8a is a cell surface glycoprotein that is expressed on cytotoxic T cells, which play a critical role in the immune response against viral infections and cancer. The FITC Anti-Human CD8a Antibody[OKT-8] can be used to identify and quantify CD8a-positive T cells in various biological samples, including blood, lymph nodes, and tumors. This antibody can also be used to study the activation and differentiation of CD8a-positive T cells, as well as their interactions with other immune cells.

The FITC Anti-Human CD8a Antibody[OKT-8] is a high-quality research tool that offers excellent sensitivity and specificity for detecting CD8a-positive T cells. This antibody is supplied in a convenient format and can be used for a wide range of applications, including basic research, drug discovery, and clinical diagnostics. With its reliable performance and broad utility, the FITC Anti-Human CD8a Antibody[OKT-8] is an essential tool for any researcher studying the immune system and its role in health and disease.